Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jan;55(1):455-6.
doi: 10.1128/AAC.01298-10. Epub 2010 Nov 15.

High mortality among older patients treated with pentavalent antimonials for visceral leishmaniasis in East Africa and rationale for switch to liposomal amphotericin B

High mortality among older patients treated with pentavalent antimonials for visceral leishmaniasis in East Africa and rationale for switch to liposomal amphotericin B

François Chappuis et al. Antimicrob Agents Chemother. 2011 Jan.
No abstract available

PubMed Disclaimer

References

    1. Collin, S., R. Davidson, K. Ritmeijer, K. Keus, Y. Melaku, S. Kipngetich, and C. Davies. 2004. Conflict and kala-azar: determinants of adverse outcomes of kala-azar among patients in southern Sudan. Clin. Infect. Dis. 38:612-619. - PubMed
    1. Herrero, M., G. Orfanos, D. Argaw, A. Mulugeta, P. Aparicio, F. Parreño, O. Bernal, D. Rubens, J. Pedraza, M. A. Lima, L. Flevaud, P. P. Palma, S. Bashaye, J. Alvar, and C. Bern. 2009. Natural history of a visceral leishmaniasis outbreak in highland Ethiopia. Am. J. Trop. Med. Hyg. 81:373-377. - PubMed
    1. Lyons, S., H. Veeken, and J. Long. 2003. Visceral leishmaniasis and HIV in Tigray, Ethiopia. Trop. Med. Int. Health 8:733-739. - PubMed
    1. Mueller, Y., D. B. Mbulamberi, P. Odermatt, A. Hoffmann, L. Loutan, and F. Chappuis. 2009. Risk factors for in-hospital mortality of visceral leishmaniasis patients in eastern Uganda. Trop. Med. Int. Health 14:910-917. - PubMed
    1. Oliveira, A. L., Y. M. Brustoloni, T. D. Fernandes, M. E. Dorval, R. V. Cunha, and M. N. Boia. 2009. Severe adverse reactions to meglumine antimoniate in the treatment of visceral leishmaniasis: a report of 13 cases in the southwestern region of Brazil. Trop. Doct. 39:180-182. - PubMed

LinkOut - more resources